167 related articles for article (PubMed ID: 21501597)
21. Helicobacter pylori peptidoglycan modifications confer lysozyme resistance and contribute to survival in the host.
Wang G; Lo LF; Forsberg LS; Maier RJ
mBio; 2012 Dec; 3(6):e00409-12. PubMed ID: 23221800
[TBL] [Abstract][Full Text] [Related]
22. Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.
Hu X; Nguyen KT; Jiang VC; Lofland D; Moser HE; Pei D
J Med Chem; 2004 Sep; 47(20):4941-9. PubMed ID: 15369398
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases.
Sink R; Kovac A; Tomasić T; Rupnik V; Boniface A; Bostock J; Chopra I; Blanot D; Masic LP; Gobec S; Zega A
ChemMedChem; 2008 Sep; 3(9):1362-70. PubMed ID: 18651694
[TBL] [Abstract][Full Text] [Related]
24. High-throughput screening of enzyme inhibition using an inhibitor gradient generated in a microchannel.
Garcia E; Hasenbank MS; Finlayson B; Yager P
Lab Chip; 2007 Feb; 7(2):249-55. PubMed ID: 17268628
[TBL] [Abstract][Full Text] [Related]
25. Small molecule inhibitors of peptidoglycan synthesis targeting the lipid II precursor.
Derouaux A; Turk S; Olrichs NK; Gobec S; Breukink E; Amoroso A; Offant J; Bostock J; Mariner K; Chopra I; Vernet T; Zervosen A; Joris B; Frère JM; Nguyen-Distèche M; Terrak M
Biochem Pharmacol; 2011 May; 81(9):1098-105. PubMed ID: 21356201
[TBL] [Abstract][Full Text] [Related]
26. Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach.
Perdih A; Kovac A; Wolber G; Blanot D; Gobec S; Solmajer T
Bioorg Med Chem Lett; 2009 May; 19(10):2668-73. PubMed ID: 19369074
[TBL] [Abstract][Full Text] [Related]
27. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
28. An ultraefficient affinity-based high-throughout screening process: application to bacterial cell wall biosynthesis enzyme MurF.
Comess KM; Schurdak ME; Voorbach MJ; Coen M; Trumbull JD; Yang H; Gao L; Tang H; Cheng X; Lerner CG; McCall JO; Burns DJ; Beutel BA
J Biomol Screen; 2006 Oct; 11(7):743-54. PubMed ID: 16973923
[TBL] [Abstract][Full Text] [Related]
29. Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae.
Davis KM; Akinbi HT; Standish AJ; Weiser JN
PLoS Pathog; 2008 Dec; 4(12):e1000241. PubMed ID: 19079576
[TBL] [Abstract][Full Text] [Related]
30. Structure-based discovery and experimental verification of novel AI-2 quorum sensing inhibitors against Vibrio harveyi.
Li M; Ni N; Chou HT; Lu CD; Tai PC; Wang B
ChemMedChem; 2008 Aug; 3(8):1242-9. PubMed ID: 18537200
[TBL] [Abstract][Full Text] [Related]
31. 5-Benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial Mur ligases.
Tomasić T; Zidar N; Kovac A; Turk S; Simcic M; Blanot D; Müller-Premru M; Filipic M; Grdadolnik SG; Zega A; Anderluh M; Gobec S; Kikelj D; Peterlin Masic L
ChemMedChem; 2010 Feb; 5(2):286-95. PubMed ID: 20024979
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD.
Strancar K; Blanot D; Gobec S
Bioorg Med Chem Lett; 2006 Jan; 16(2):343-8. PubMed ID: 16271472
[TBL] [Abstract][Full Text] [Related]
33. High-throughput assays for promiscuous inhibitors.
Feng BY; Shelat A; Doman TN; Guy RK; Shoichet BK
Nat Chem Biol; 2005 Aug; 1(3):146-8. PubMed ID: 16408018
[TBL] [Abstract][Full Text] [Related]
34. Identification of the binding site of Brucella VirB8 interaction inhibitors.
Smith MA; Coinçon M; Paschos A; Jolicoeur B; Lavallée P; Sygusch J; Baron C
Chem Biol; 2012 Aug; 19(8):1041-8. PubMed ID: 22921071
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the pneumococcal virulence factor StrH and molecular insights into N-glycan recognition and hydrolysis.
Pluvinage B; Higgins MA; Abbott DW; Robb C; Dalia AB; Deng L; Weiser JN; Parsons TB; Fairbanks AJ; Vocadlo DJ; Boraston AB
Structure; 2011 Nov; 19(11):1603-14. PubMed ID: 22078560
[TBL] [Abstract][Full Text] [Related]
36. Phenylimidazole derivatives as new inhibitors of bacterial enoyl-ACP reductase FabK.
Kitagawa H; Ozawa T; Takahata S; Iida M
Bioorg Med Chem Lett; 2007 Sep; 17(17):4982-6. PubMed ID: 17600706
[TBL] [Abstract][Full Text] [Related]
37. Peptide deformylase inhibitors.
Aubart K; Zalacain M
Prog Med Chem; 2006; 44():109-43. PubMed ID: 16697896
[No Abstract] [Full Text] [Related]
38. Stimulation of PgdA-dependent peptidoglycan N-deacetylation by GpsB-PBP A1 in Listeria monocytogenes.
Rismondo J; Wamp S; Aldridge C; Vollmer W; Halbedel S
Mol Microbiol; 2018 Feb; 107(4):472-487. PubMed ID: 29215169
[TBL] [Abstract][Full Text] [Related]
39. Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors.
Park H; Bhattarai BR; Ham SW; Cho H
Eur J Med Chem; 2009 Aug; 44(8):3280-4. PubMed ID: 19269068
[TBL] [Abstract][Full Text] [Related]
40. Inactivation of the wall-associated de-N-acetylase (PgdA) of Listeria monocytogenes results in greater susceptibility of the cells to induced autolysis.
Popowska M; Kusio M; Szymanska P; Markiewicz Z
J Microbiol Biotechnol; 2009 Sep; 19(9):932-45. PubMed ID: 19809250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
